X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (765) 765
Patent (51) 51
Conference Proceeding (11) 11
Publication (5) 5
Book Review (4) 4
Book Chapter (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (374) 374
male (290) 290
oncology (180) 180
aged (171) 171
middle aged (168) 168
index medicus (141) 141
female (122) 122
urology & nephrology (111) 111
prostate cancer (107) 107
adult (102) 102
cancer (89) 89
japan (68) 68
prostatic neoplasms - drug therapy (66) 66
aged, 80 and over (65) 65
treatment outcome (54) 54
bladder cancer (52) 52
human necessities (50) 50
hygiene (48) 48
medical or veterinary science (48) 48
preparations for medical, dental, or toilet purposes (48) 48
animals (47) 47
carcinoma (47) 47
prognosis (47) 47
androgen antagonists - therapeutic use (45) 45
chemistry (44) 44
kidney neoplasms - pathology (44) 44
metallurgy (44) 44
antineoplastic combined chemotherapy protocols - therapeutic use (42) 42
chemotherapy (42) 42
disease-free survival (42) 42
microbiology (41) 41
neoplasm staging (41) 41
prostatic neoplasms - pathology (41) 41
kidney neoplasms - drug therapy (40) 40
urology (40) 40
urinary bladder neoplasms - pathology (39) 39
biochemistry (37) 37
care and treatment (37) 37
beer (36) 36
carcinoma, renal cell - drug therapy (36) 36
enzymology (36) 36
mutation or genetic engineering (36) 36
renal cell carcinoma (36) 36
spirits (36) 36
survival rate (36) 36
vinegar (36) 36
wine (36) 36
urinary bladder neoplasms - drug therapy (35) 35
asia (33) 33
antineoplastic agents - therapeutic use (32) 32
metastasis (32) 32
prostate-specific antigen - blood (32) 32
specific therapeutic activity of chemical compounds ormedicinal preparations (32) 32
therapy (32) 32
tumors (32) 32
foods or foodstuffs (31) 31
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (31) 31
preservation of foods or foodstuffs, in general (31) 31
research (31) 31
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (31) 31
their treatment, not covered by other classes (31) 31
drug administration schedule (30) 30
analysis (27) 27
immunotherapy (27) 27
antineoplastic agents, hormonal - therapeutic use (26) 26
combined modality therapy (26) 26
japan - epidemiology (26) 26
risk factors (26) 26
carcinoma, renal cell - pathology (24) 24
expression (24) 24
retrospective studies (24) 24
survival (24) 24
cisplatin - administration & dosage (23) 23
culture media (23) 23
medicine & public health (23) 23
mice (23) 23
prostatic neoplasms - diagnosis (23) 23
risk (23) 23
compositions thereof (22) 22
follow-up studies (22) 22
microorganisms or enzymes (22) 22
original (22) 22
propagating, preserving or maintaining microorganisms (22) 22
prostatic neoplasms - mortality (22) 22
men (21) 21
time factors (21) 21
trial (21) 21
prostatic neoplasms - epidemiology (20) 20
quality of life (20) 20
rats (20) 20
administration, intravesical (19) 19
prostatectomy (19) 19
prostatic neoplasms - prevention & control (19) 19
prostatic neoplasms - therapy (19) 19
radical prostatectomy (19) 19
antineoplastic agents - adverse effects (18) 18
disease progression (18) 18
health aspects (18) 18
oncology, experimental (18) 18
prospective studies (18) 18
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (781) 781
Japanese (84) 84
French (26) 26
German (15) 15
Chinese (5) 5
Korean (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Urology, ISSN 1759-4812, 01/2017, Volume 14, Issue 1, pp. 12 - 13
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 01/2019, Volume 46, Issue 1, pp. 34 - 35
Journal Article
Japanese Journal of Cancer and Chemotherapy, ISSN 0385-0684, 01/2018, Volume 45, Issue 1, p. 25
Journal Article
Japanese Journal of Clinical Oncology, ISSN 0368-2811, 01/2016, Volume 46, Issue 1, pp. 23 - 30
The characteristics of urological cancer in Japan can be summarized in the following points. (i) As the onset of this type of cancer is typically seen in... 
Bladder cancer | Prostate cancer | Japan | Kidney cancer | INTRAVESICAL CHEMOTHERAPY | BLADDER-CANCER | EFFICACY | SAFETY | J-CAP | RENAL-CELL CARCINOMA | kidney cancer | prostate cancer | THERAPY | ONCOLOGY | bladder cancer | PROSTATE-CANCER | Japan - epidemiology | Urologic Neoplasms - epidemiology | Asia | Humans | Aging | Quality of Life | Aged
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 01/2017, Volume 44, Issue 1, p. 28
Journal Article
Japanese Journal of Cancer and Chemotherapy, ISSN 0385-0684, 01/2017, Volume 44, Issue 1, p. 28
Journal Article
Japanese Journal of Clinical Oncology, ISSN 0368-2811, 04/2016, Volume 46, Issue 4, pp. 299 - 302
Journal Article
癌症生物学与医学:英文版, ISSN 2095-3941, 2013, Volume 10, Issue 4, pp. 187 - 191
There are notable differences in the incidence and mortality rates for prostate cancer between Asia and Western countries. It is also recognized that there are... 
前列腺癌 | 亚洲 | ADT | 雄激素 | 治疗方案 | 西方国家 | 发展趋势 | 睾丸激素 | Androgen depletion therapy | Asia | Prostate cancer | Working groups | Invasiveness | Endocrine therapy | Metastasis | Drug development | Patients | Cancer therapies | Metastases | Studies | Testosterone | Androgens | Castration | Collaboration | Clinical medicine | Trends | Prostate | Tumors | prostate cancer | Review
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 01/2016, Volume 43, Issue 1, p. 44
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 01/2016, Volume 43, Issue 1, p. 44
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 01/2016, Volume 74, Issue 1, pp. 13 - 19
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 01/2016, Volume 74, Issue 1, p. 13
Incidence and mortality rates of the prostate cancer are quite different between countries in the world. Such diversity may relate not only with the genetic... 
Isoflavones - blood | Diet | Humans | Risk Factors | Aging | Male | Prostatic Neoplasms - diagnosis | Prostatic Neoplasms - prevention & control | Equol - biosynthesis | Prostate-Specific Antigen - blood | Prostatic Neoplasms - epidemiology
Journal Article
NATURE REVIEWS UROLOGY, ISSN 1759-4812, 01/2017, Volume 14, Issue 1, pp. 12 - 13
Multiple BCG strains are used for intravesical instillation treatment of non-muscle-invasive bladder cancer but no large randomized studies comparing these... 
UROLOGY & NEPHROLOGY | BLADDER-CANCER
Journal Article
Current urology reports, 11/2016, Volume 17, Issue 11, p. 84
The clinical efficacy of combined therapy (CAB) has been clearly recognized by the results of the STRIVE trial. Although enzalutamide has shown a stronger... 
Humans | Androgen Antagonists - therapeutic use | Quality of Life | Androgens - therapeutic use | Male | Prostatic Neoplasms - diagnosis | Drug Therapy, Combination | Phenylthiohydantoin - analogs & derivatives | Prostatic Neoplasms - drug therapy | Randomized Controlled Trials as Topic
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 338 - 348
Summary Background Orteronel is an investigational, partially selective inhibitor of CYP 17,20-lyase in the androgen signalling pathway, a validated... 
Hematology, Oncology and Palliative Medicine | MITOXANTRONE | ONCOLOGY | MEN | END-POINTS | ABIRATERONE ACETATE | INCREASED SURVIVAL | DOCETAXEL | ENZALUTAMIDE | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Prostatic Neoplasms, Castration-Resistant - enzymology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Male | North America | Prostatic Neoplasms, Castration-Resistant - pathology | Time Factors | Prednisone - administration & dosage | Double-Blind Method | Europe | Risk Factors | Adenocarcinoma - enzymology | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Adenocarcinoma - drug therapy | Cytochrome P-450 Enzyme Inhibitors - administration & dosage | Adenocarcinoma - secondary | Disease Progression | New Zealand | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Naphthalenes - administration & dosage | Intention to Treat Analysis | Aged | Prostatic Neoplasms, Castration-Resistant - mortality | Steroid 17-alpha-Hydroxylase - metabolism | Australia | Adenocarcinoma - mortality | Medical colleges | Care and treatment | Chemotherapy | Corticosteroids | Cytochrome P-450 | Clinical trials | Prednisone | Metastasis | Prostate cancer | Cancer | Steroids
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 01/2015, Volume 42, Issue 1, p. 26
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 01/2015, Volume 42, Issue 1, p. 26
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.